Time Passages: Bruce Goldsmith out at Jim Wilson's gene therapy biotech; Flagship reveals Michael Severino’s CEO gig
→ When Passage Bio readjusted its pipeline priorities, pruned its workforce by 13% and saw its R&D chief Eliseo Salinas walk out in March …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
